01.06.2013 Views

Statistical Methods in Medical Research 4ed

Statistical Methods in Medical Research 4ed

Statistical Methods in Medical Research 4ed

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

726 Laboratory assays<br />

This relationship can be fitted by standard multiple regression methods (§11.6),<br />

and the potency r (ˆ b T=b S) estimated by<br />

R ˆ bT=bS: …20:17†<br />

The residual variance of y is estimated by the usual residual MSq, s 2 , and the<br />

variances and covariance of bS and bT are obta<strong>in</strong>ed from (11.43) and (11.44):<br />

var…bS† ˆc11s 2 , var…bT† ˆc22s 2 , cov…bS, bT† ˆc12s 2 : …20:18†<br />

Approximate confidence limits for r are obta<strong>in</strong>ed by the follow<strong>in</strong>g formula<br />

derived from (5.17):<br />

var…R† ˆ s2<br />

b2 …c22 2Rc12 ‡ R<br />

S<br />

2 c11†: …20:19†<br />

A more exact solution, us<strong>in</strong>g Fieller's theorem, is available, as <strong>in</strong> (5.15), but is not<br />

normally required with assays of this type.<br />

For numerical examples of the calculations, see F<strong>in</strong>ney (1978, Chapter 7).<br />

The adequacy of the model <strong>in</strong> a slope-ratio assay can be tested by a rather<br />

elegant analysis of variance procedure. Suppose the design is of a 1 ‡ kS ‡ kT<br />

type; that is, there is one group of `blanks' and there are kS dose groups of S and<br />

kT dose groups of T. Suppose also that there is replication at some or all of the<br />

dose levels, giv<strong>in</strong>g n observations <strong>in</strong> all. A standard analysis (as described on<br />

p. 360) leads to the follow<strong>in</strong>g subdivision of DF:<br />

Between doses kS ‡ kT<br />

Regression 2<br />

Deviations from model kS ‡ kT 2<br />

With<strong>in</strong> doses n kS kT 1<br />

n 1<br />

The SSq for deviations from the model can be subdivided <strong>in</strong>to the follow<strong>in</strong>g parts:<br />

Blanks 1<br />

Intersection 1<br />

Non-l<strong>in</strong>earity for non-zero doses kS ‡ kT 4<br />

kS ‡ kT 2<br />

The SSq for `blanks' <strong>in</strong>dicates whether the `blanks' observations are<br />

sufficiently consistent with the rema<strong>in</strong>der. It can be obta<strong>in</strong>ed by refitt<strong>in</strong>g the<br />

multiple regression with an extra dummy variable (1 for `blanks', 0 otherwise),<br />

and not<strong>in</strong>g the reduction <strong>in</strong> the deviations SSq. A significant variance-ratio test<br />

for `blanks' might <strong>in</strong>dicate non-l<strong>in</strong>earity for very low doses; if the rema<strong>in</strong><strong>in</strong>g tests<br />

were satisfactory, the assay could still be analysed adequately by omitt<strong>in</strong>g the<br />

`blanks'.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!